Anlotinib as a molecular targeted therapy for tumors.
Oncol Lett. 2020 Aug;20(2):1001-1014. doi: 10.3892/ol.2020.11685. Epub 2020 May 28.
Oncol Lett. 2020.
PMID: 32724339
Free PMC article.
Review.